Proteogenomic Markers of Chemotherapy Resistance and Response in Triple-Negative Breast CancerMeenakshi Anurag, Matthew J. Ellis, Eric J. Jaehnig et al.|Cancer Discovery|2022Cited by 139
Osteoprogenitor-GMP crosstalk underpins solid tumor-induced systemic immunosuppression and persists after tumor removalXiaoxin Hao, Xiang H.-F. Zhang, Yichao Shen et al.|Cell stem cell|2023Cited by 59
Solid tumour-induced systemic immunosuppression involves dichotomous myeloid–B cell interactionsXiaoxin Hao, Xiang H.-F. Zhang, Yichao Shen et al.|Nature Cell Biology|2024Cited by 16
Proteogenomic Approaches for the Identification of NF1/Neurofibromin-depleted Estrogen Receptor–positive Breast Cancers for Targeted TreatmentBeom-Jun Kim, Eric C. Chang, Anran Chen et al.|Cancer Research Communications|2023Cited by 8
Supplementary Table from Proteogenomic Markers of Chemotherapy Resistance and Response in Triple-Negative Breast CancerMeenakshi Anurag, Matthew J. Ellis, Eric J. Jaehnig et al.|Unknown|2023Cited by 0